Inventor
CONZEN SUZANNE D
US13 patents
⚠️ This page may combine multiple inventors who share the name “CONZEN SUZANNE D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV CHICAGO
12 patentsUS9623032B2Apr 18, 2017
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO35 citations97
US9149485B2Oct 6, 2015
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO42 citations97
US9801893B2Oct 31, 2017
Method of treatment for prostate cancer with androgen receptor antagonists and glucocorticoid receptor antagonists
UNIV CHICAGO37 citations95
US9289436B2Mar 22, 2016
Method of treatment of prostate cancer with androgen receptor and glucocorticoid receptor antagonists
UNIV CHICAGO57 citations95
US10441596B2Oct 15, 2019
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO7 citations83
US10300076B2May 28, 2019
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists
UNIV CHICAGO4 citations82
US11234990B2Feb 1, 2022
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO2 citations72
US10071130B2Sep 11, 2018
Methods and compositions related to Hsp90 inhibitors and breast cancer
UNIV CHICAGO6 citations72
US10729699B2Aug 4, 2020
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists after anticancer therapy
UNIV CHICAGO3 citations71
US12280066B2Apr 22, 2025
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO0 citations62
US11883417B2Jan 30, 2024
Methods and compositions related to glucocorticoid receptor antagonists and breast cancer
UNIV CHICAGO0 citations62
US11564932B2Jan 31, 2023
Methods of treating castration-resistant prostate cancer with glucocorticoid receptor antagonists and anti-androgen receptor therapy
UNIV CHICAGO0 citations60